Lyell Immunopharma Inc

NASDAQ:LYEL   12:59:07 PM EDT
9.33
-0.07 (-0.74%)
Earnings Announcements

Lyell Posts Quarterly Revenue $2.8 Million

Published: 11/12/2021 14:46 GMT
Lyell Immunopharma Inc (LYEL) - Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business Highlights.
Lyell Immunopharma Inc - Qtrly Revenue $2.8 Million Versus $1.1 Million.
Lyell Immunopharma Inc - Qtrly Net Loss $48.9 Million Versus $35.7 Million.
Revenue is expected to be $2.67 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $3 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.